BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang FQ, Rao GR, Wang GQ, Li YQ, Xie Y, Zhang ZQ, Deng CL, Mao Q, Li J, Zhao W, Wang MR, Han T, Chen SJ, Pan C, Tan DM, Shang J, Zhang MX, Zhang YX, Yang JM, Chen GM. Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy. World J Gastroenterol 2017; 23(2): 306-317 [PMID: 28127204 DOI: 10.3748/wjg.v23.i2.306]
URL: https://www.wjgnet.com/1007-9327/full/v23/i2/306.htm
Number Citing Articles
1
Michael P. Veve, Vasilios Athans. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2018; 40: 383 doi: 10.1016/bs.seda.2018.06.006
2
Shuaibu Hudu, Abdulgafar Jimoh, Kasimu Ibrahim, Ahmed Alshrari. Hepatitis B Therapeutic Vaccine: A Patent ReviewPharmaceuticals 2022; 15(12): 1542 doi: 10.3390/ph15121542
3
Monique Ribeiro de Lima, Ana Cristina C. S. Leandro, Andreia Lamoglia de Souza, Marcio Mantuano Barradas, Eric Henrique Roma, Ana Teresa Gomes Fernandes, Gabrielle Galdino-Silva, Joyce Katiuccia M. Ramos Carvalho, Renato Sergio Marchevsky, Janice M. C. Oliveira Coelho, Eduardo Dantas Casillo Gonçalves, John L. VandeBerg, Celio Lopes Silva, Maria da Gloria Bonecini-Almeida. Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA-hsp65 Tuberculosis Vaccine in Cynomolgus MonkeysVaccines 2023; 11(12): 1863 doi: 10.3390/vaccines11121863
4
Sanyuan Shi, Luchen Zhang, Anjie Zheng, Fang Xie, Samuel Kesse, Yang Yang, Jinliang Peng, Yuhong Xu. Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor modelsCancer Immunology, Immunotherapy 2024; 73(12) doi: 10.1007/s00262-024-03838-8
5
Aslıhan Demirel, Resat Ozaras. Viral Hepatitis: Chronic Hepatitis B2018; : 105 doi: 10.1007/978-3-319-93449-5_9
6
Mekuanint Geta, Getachew Mengistu, Endalew Yizengaw, Tsegahun Manyzewal, Asrat Hailu, Yimtubeznash Woldeamanuel. Efficacy and safety of therapeutic vaccines for the treatment of chronic hepatitis B: A systematic review and meta-analysis of randomized controlled trials updateMedicine 2024; 103(35): e39344 doi: 10.1097/MD.0000000000039344
7
Aubrey M. Demchuk, Trushar R. Patel. The biomedical and bioengineering potential of protein nanocompartmentsBiotechnology Advances 2020; 41: 107547 doi: 10.1016/j.biotechadv.2020.107547
8
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis BAnnals of Hepatology 2025; 30(1): 101533 doi: 10.1016/j.aohep.2024.101533
9
Sunshine Littlecreek, Bonnie L. Firestein. Current methods of electroporation for efficient vaccination uptakeTECHNOLOGY 2020; 8(01n02): 1 doi: 10.1142/S2339547820300012
10
Chenggong Zhu, Minjie Tang, Ya Fu, Zhen Xun, Caorui Lin, Songhang Wu, Tianbin Chen, Yongbin Zeng, Bin Yang, Qishui Ou, Can Liu. Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencingInternational Journal of Medical Microbiology 2024; 315: 151619 doi: 10.1016/j.ijmm.2024.151619
11
Diahann TSL Jansen, Yingying Dou, Janet W de Wilde, Andrea M Woltman, Sonja I Buschow. Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measuresClinical & Translational Immunology 2021; 10(1) doi: 10.1002/cti2.1232
12
Chelsea Edelblute, Cathryn Mangiamele, Richard Heller. Moderate Heat-Assisted Gene Electrotransfer for Cutaneous Delivery of a DNA Vaccine Against Hepatitis B VirusHuman Gene Therapy 2021;  doi: 10.1089/hum.2021.037
13
Efthymios P Tsounis, Athanasia Mouzaki, Christos Triantos. Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cureWorld Journal of Gastroenterology 2021; 27(41): 7005-7013 doi: 10.3748/wjg.v27.i41.7005
14
Chinyang Chang, Jiao Sun, Hiroki Hayashi, Ayano Suzuki, Yuko Sakaguchi, Hiroshi Miyazaki, Tomoyuki Nishikawa, Hironori Nakagami, Kunihiko Yamashita, Yasufumi Kaneda. Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet InjectorAAPS PharmSciTech 2020; 21(1) doi: 10.1208/s12249-019-1564-z
15
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic reviewJournal of Gastroenterology 2020; 55(5): 496 doi: 10.1007/s00535-020-01680-0
16
Seng Gee Lim, Jennielyn Agcaoili, Nurun Nisa Amatullah De Souza, Edwin Chan. Therapeutic vaccination for chronic hepatitis B: A systematic review and meta‐analysisJournal of Viral Hepatitis 2019; 26(7): 803 doi: 10.1111/jvh.13085
17
Tamsin Cargill, Eleanor Barnes. Therapeutic vaccination for treatment of chronic hepatitis BClinical and Experimental Immunology 2021; 205(2): 106 doi: 10.1111/cei.13614
18
Kunihiko Yamashita. Therapeutic Vaccines as Novel Immunotherapy2019; : 57 doi: 10.1007/978-981-32-9628-2_6
19
Ling Li, Yingying Zhang, Yage Wu, Zhengge Wang, Wandi Cui, Chunhong Zhang, Jinglin Wang, Yongchun Liu, Peng Yang. Protein‐Based Controllable Nanoarchitectonics for Desired ApplicationsAdvanced Functional Materials 2024; 34(29) doi: 10.1002/adfm.202315509